With the generous financial support of a number of individuals and other bodies, the NCBRSI opened at the end of March 2012, as a unit within the Blizard Institute, Barts & the London School of Medicine and Dentistry.
In March 2012 the UK's first National Centre for Bowel Research and Surgical Innovation (NCBRSI) became operational.
The National Centre for Bowel Disease and Surgical Innovation (NCBRSI) is a multi-disciplinary unit within the Blizard Institute, the largest institute within Barts & the London School of Medicine and Dentistry. The NCBRSI is comprised of three interlinked units – A human tissue laboratory (experimental medicine), an interventional effectiveness unit (clinical trials), and a surgical innovation unit.
It has been organised to bring together key research disciplines, with the aim of fostering collaboration and driving progress through pooled expertise and engagement with other clinical and academic units, businesses and patients nationwide.
Experimental medicine – investigation in humans to identify the cause of disease and to test the validity and importance of new discoveries and treatments.
Outcomes based research – clinical trials of novel interventions and surgical procedures to save lives and improve quality of life of people with chronic disease.
Innovation – in diagnostics and surgical techniques to better treat patients, save lives and improve the quality of people's lives.